KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus

被引:128
作者
Gossner, L
May, A
Stolte, M
Seitz, G
Hahn, EG
Ell, C
机构
[1] Dept Med 2, Wiesbaden, Germany
[2] Inst Pathol, Bayreuth, Germany
[3] Inst Pathol, Bamberg, Germany
[4] Univ Erlangen Nurnberg, Dept Med 1, D-8520 Erlangen, Germany
关键词
D O I
10.1016/S0016-5107(99)70438-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The rising incidence of esophageal adenocarcinoma in western countries requires a new strategy in the management of dysplasia in Barren's esophagus, Esophagectomy, which has high morbidity and mortality rates, has been recommended to treat patients with severe dysplasia. Strictly superficial laser coagulation with tissue ablation therefore is a desirable option for the management of dysplasia in Barrett's esophagus because the tissue to be ablated is only about 2 mm thick, Potassium-titanyl-phosphate (KTP) laser light with a wavelength of 532 nm is preferentially absorbed by hemoglobin and therefore combines excellent coagulation with limited tissue penetration. We report first clinical results with KTP laser superficial vaporization of dysplasia and early cancer in Barren's esophagus. Methods: Eight men and 2 women 43 to 84 years of age with short segments of Barrett's esophagus or traditional Barrett's esophagus and histologically proved low-grade (n = 4) and high-grade (n = 4) dysplasia or early adenocarcinoma (n = 2) were selected for this pilot study. For all patients thermal endoscopic destruction was conducted with a frequency-doubled neodymium:yttrium-aluminum-garnet (Nd:YAG) KTP laser system. Laser therapy was performed by means of the free-beam method with coaxial insufflation of gas. An average of 2.4 sessions per patient were required for ablation of the Barrett's mucosa, Results: Two to three days after laser treatment the response of the ablated mucosa was assessed with endoscopy and biopsy. Samples taken showed fibrinoid necrosis of the mucosal layer. A complete response was obtained for all 10 patients. Replacement by normal squamous cell epithelium was induced in combination with acid suppression therapy of up to 80 mg omeprazole daily. No complications occurred. In two patients biopsy showed specialized mucosa beneath the restored squamous cell epithelial layer. Follow-up times were as long as 15 months (mean value 10.6 months). Conclusions: KTP laser destruction of Barren's esophagus induced mucosal regeneration with normal squamous cell epithelium in combination with acid suppression. Limitation of the depth of thermal destruction in Barrett's esophagus minimizes risk for perforation or stricture formation. KTP laser ablation of Barrett's esophagus seems to be feasible and safe in short segments of Barrett's esophagus with dysplasia or early cancer.
引用
收藏
页码:8 / 12
页数:5
相关论文
共 29 条
  • [11] Gossner L, 1996, GASTROINTEST ENDOSC, V43, P18
  • [12] GOSSNER L, IN PRESS ENDOSCOPY
  • [13] BARRETTS ESOPHAGUS - DEVELOPMENT OF DYSPLASIA AND ADENOCARCINOMA
    HAMEETEMAN, W
    TYTGAT, GNJ
    HOUTHOFF, HJ
    VANDENTWEEL, JG
    [J]. GASTROENTEROLOGY, 1989, 96 (05) : 1249 - 1256
  • [14] Barrett's esophagus with high-grade dysplasia - An indication for prophylactic esophagectomy
    Heitmiller, RF
    Redmond, M
    Hamilton, SR
    [J]. ANNALS OF SURGERY, 1996, 224 (01) : 66 - 71
  • [15] HOLSCHER AH, 1995, CANCER-AM CANCER SOC, V76, P178, DOI 10.1002/1097-0142(19950715)76:2<178::AID-CNCR2820760204>3.0.CO
  • [16] 2-D
  • [17] AN ENDOSCOPIC BIOPSY PROTOCOL CAN DIFFERENTIATE HIGH-GRADE DYSPLASIA FROM EARLY ADENOCARCINOMA IN BARRETTS-ESOPHAGUS
    LEVINE, DS
    HAGGITT, RC
    BLOUNT, PL
    RABINOVITCH, PS
    RUSCH, VW
    REID, BJ
    [J]. GASTROENTEROLOGY, 1993, 105 (01) : 40 - 50
  • [18] TIME-RELATED CHANGES IN CHARACTERISTICS OF PROGNOSTIC-SIGNIFICANCE IN CARCINOMAS OF THE ESOPHAGUS AND CARDIA
    LUND, O
    HASENKAM, JM
    AAGAARD, MT
    KIMOSE, HH
    [J]. BRITISH JOURNAL OF SURGERY, 1989, 76 (12) : 1301 - 1307
  • [19] MCBRIDE MA, 1995, AM J GASTROENTEROL, V90, P2029
  • [20] SURGICAL RESECTION FOR STAGE-I CANCER OF THE ESOPHAGUS AND CARDIA
    MOGHISSI, K
    [J]. BRITISH JOURNAL OF SURGERY, 1992, 79 (09) : 935 - 937